Variant report

Variant	nsv874896
Chromosome Location	chr2:113874122-113875892
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:113875071-113875082	K562	blood:	n/a	n/a
2	ARID3A	chr2:113875315-113875384	K562	blood:	n/a	n/a
3	BHLHE40	chr2:113875070-113875507	K562	blood:	n/a	n/a
4	CTCF	chr2:113875420-113875570	HMEC	breast:	n/a	n/a
5	CUX1	chr2:113874825-113874981	K562	blood:	n/a	n/a
6	CUX1	chr2:113874484-113874556	GM12878	blood:	n/a	n/a
7	E2F4	chr2:113875089-113875413	MCF10A-Er-Src	breast:	n/a	n/a
8	E2F6	chr2:113875152-113875371	K562	blood:	n/a	n/a
9	EBF1	chr2:113873789-113874376	GM12878	blood:	n/a	chr2:113874030-113874041
10	EBF1	chr2:113873829-113874147	GM12878	blood:	n/a	chr2:113874030-113874041
11	EBF1	chr2:113873642-113874300	GM12878	blood:	n/a	chr2:113874030-113874041
12	EGR1	chr2:113873927-113874182	GM12878	blood:	n/a	chr2:113874018-113874027
13	EGR1	chr2:113875256-113875520	K562	blood:	n/a	n/a
14	EGR1	chr2:113875116-113875674	MCF-7	breast:	n/a	n/a
15	EGR1	chr2:113873923-113874152	GM12878	blood:	n/a	chr2:113874018-113874027
16	ELF1	chr2:113873733-113874200	GM12878	blood:	n/a	chr2:113874015-113874026 chr2:113874179-113874190
17	ELF1	chr2:113873759-113874214	GM12878	blood:	n/a	chr2:113874015-113874026 chr2:113874179-113874190
18	EP300	chr2:113875249-113875386	K562	blood:	n/a	n/a
19	EP300	chr2:113875083-113875605	MCF-7	breast:	n/a	n/a
20	ETS1	chr2:113873816-113874235	GM12878	blood:	n/a	chr2:113874018-113874027 chr2:113874019-113874030 chr2:113874018-113874032
21	FOS	chr2:113875049-113875535	MCF10A-Er-Src	breast:	n/a	chr2:113875324-113875332 chr2:113875323-113875333 chr2:113875323-113875334 chr2:113875323-113875333
22	FOS	chr2:113875093-113875509	MCF10A-Er-Src	breast:	n/a	chr2:113875324-113875332 chr2:113875323-113875333 chr2:113875323-113875334 chr2:113875323-113875333
23	FOS	chr2:113874989-113875516	MCF10A-Er-Src	breast:	n/a	chr2:113875324-113875332 chr2:113875323-113875333 chr2:113875323-113875334 chr2:113875323-113875333
24	FOS	chr2:113875075-113875509	MCF10A-Er-Src	breast:	n/a	chr2:113875324-113875332 chr2:113875323-113875333 chr2:113875323-113875334 chr2:113875323-113875333
25	FOSL2	chr2:113875037-113875627	MCF-7	breast:	n/a	chr2:113875324-113875332 chr2:113875323-113875333 chr2:113875323-113875334 chr2:113875323-113875333
26	FOXM1	chr2:113873776-113874130	GM12878	blood:	n/a	n/a
27	GATA1	chr2:113874927-113876326	PBDE	blood:	n/a	chr2:113875293-113875303 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875305 chr2:113875295-113875302 chr2:113876195-113876204 chr2:113875293-113875302 chr2:113876018-113876034 chr2:113875295-113875302
28	GATA3	chr2:113875058-113875700	MCF-7	breast:	n/a	chr2:113875293-113875303 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875305 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875302
29	GATA3	chr2:113874901-113875843	MCF-7	breast:	n/a	chr2:113875293-113875303 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875305 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875302
30	GATA3	chr2:113875120-113875456	MCF-7	breast:	n/a	chr2:113875293-113875303 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875305 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875302
31	GATA3	chr2:113875154-113875525	T-47D	breast:	n/a	chr2:113875293-113875303 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875305 chr2:113875295-113875302 chr2:113875293-113875302 chr2:113875295-113875302
32	HCFC1	chr2:113875264-113875401	K562	blood:	n/a	n/a
33	HDAC2	chr2:113875141-113875596	MCF-7	breast:	n/a	chr2:113875294-113875303
34	JUND	chr2:113875162-113875491	K562	blood:	n/a	chr2:113875324-113875332 chr2:113875323-113875333 chr2:113875323-113875334 chr2:113875323-113875333
35	MAFK	chr2:113875218-113875357	K562	blood:	n/a	n/a
36	MAX	chr2:113875052-113875441	K562	blood:	n/a	n/a
37	MAX	chr2:113874868-113875649	MCF-7	breast:	n/a	n/a
38	MAX	chr2:113875032-113875589	ECC-1	luminal epithelium:	n/a	n/a
39	MAX	chr2:113875109-113875355	K562	blood:	n/a	n/a
40	MAX	chr2:113874346-113874400	NB4	blood:	n/a	chr2:113874383-113874393
41	MAX	chr2:113874988-113875627	ECC-1	luminal epithelium:	n/a	n/a
42	MAX	chr2:113875160-113875444	K562	blood:	n/a	n/a
43	MAX	chr2:113875005-113875670	MCF-7	breast:	n/a	n/a
44	MAZ	chr2:113875208-113875492	K562	blood:	n/a	n/a
45	MAZ	chr2:113873907-113874233	GM12878	blood:	n/a	chr2:113874108-113874118
46	MTA3	chr2:113873550-113874160	GM12878	blood:	n/a	n/a
47	MYC	chr2:113875236-113875436	K562	blood:	n/a	n/a
48	MYC	chr2:113875195-113875461	MCF-7	breast:	n/a	n/a
49	MYC	chr2:113875074-113875499	MCF10A-Er-Src	breast:	n/a	n/a
50	MYC	chr2:113875074-113875554	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:113875723-113875773	SAEC	small airway:	n/a
2	chr2:113875233-113875283	Caco-2	colon:	n/a
3	chr2:113875512-113875562	BE2_C	brain:	n/a
4	chr2:113875512-113875562	AG09319	gingival:	n/a
5	chr2:113875233-113875283	NH-A	brain:	n/a
6	chr2:113875226-113875276	Hela-S3	cervix:	n/a
7	chr2:113875723-113875773	HAEpiC	amniotic membrane:	n/a
8	chr2:113875723-113875773	HRPEpiC	eye:	n/a
9	chr2:113875233-113875283	Hela-S3	cervix:	n/a
10	chr2:113875233-113875283	SK-N-MC	brain:	n/a
11	chr2:113875723-113875773	GM12878	blood:	n/a
12	chr2:113875723-113875773	ProgFib	skin:	n/a
13	chr2:113875512-113875562	NB4	blood:	n/a
14	chr2:113875292-113875342	HIPEpiC	eye:	n/a
15	chr2:113875292-113875342	SAEC	small airway:	n/a
16	chr2:113875723-113875773	NT2-D1	testis:	n/a
17	chr2:113875233-113875283	HRPEpiC	eye:	n/a
18	chr2:113875723-113875773	PrEC	prostate:	n/a
19	chr2:113875292-113875342	Caco-2	colon:	n/a
20	chr2:113875233-113875283	HUVEC	blood vessel:	n/a
21	chr2:113875292-113875342	RPTEC	kidney:	n/a
22	chr2:113875226-113875276	PrEC	prostate:	n/a
23	chr2:113875512-113875562	HRPEpiC	eye:	n/a
24	chr2:113875723-113875773	HepG2	liver:	n/a
25	chr2:113875723-113875773	HEK293	kidney:	embryo
26	chr2:113875233-113875283	K562	blood:	n/a
27	chr2:113875723-113875773	AG04450	lung:	fetal
28	chr2:113875512-113875562	HMEC	breast:	n/a
29	chr2:113875233-113875283	PFSK-1	brain:	n/a
30	chr2:113875226-113875276	LNCaP	prostate:	n/a
31	chr2:113875292-113875342	HCPEpiC	choroid plexus:	n/a
32	chr2:113875723-113875773	HEEpiC	esophagus:	n/a
33	chr2:113875512-113875562	HIPEpiC	eye:	n/a
34	chr2:113875233-113875283	AG09319	gingival:	n/a
35	chr2:113875226-113875276	AG09319	gingival:	n/a
36	chr2:113875226-113875276	SKMC	muscle:	n/a
37	chr2:113875723-113875773	BJ	skin:	n/a
38	chr2:113875226-113875276	Caco-2	colon:	n/a
39	chr2:113875233-113875283	AG04449	skin:	fetal
40	chr2:113875292-113875342	SK-N-SH_RA	brain:	n/a
41	chr2:113875512-113875562	Hepatocyte	liver:	n/a
42	chr2:113875292-113875342	PrEC	prostate:	n/a
43	chr2:113875226-113875276	NHBE	bronchial:	n/a
44	chr2:113875512-113875562	GM12878	blood:	n/a
45	chr2:113875226-113875276	HAEpiC	amniotic membrane:	n/a
46	chr2:113875292-113875342	K562	blood:	n/a
47	chr2:113875512-113875562	HCF	heart:	n/a
48	chr2:113875512-113875562	GM06990	blood:	n/a
49	chr2:113875226-113875276	HCM	heart:	n/a
50	chr2:113875226-113875276	AG04449	skin:	fetal

No.	Distal block	Cell Line	Cell type
1	chr2:113874258..113877773-chr2:113883397..113886122,3	MCF-7	breast:
2	chr2:113863108..113865660-chr2:113875310..113877504,3	MCF-7	breast:
3	chr2:113873018..113874918-chr2:113881727..113884531,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PSD4-5	chr2:113875558-113875605	NONHSAT073743
2	lnc-IL1RN-1	chr2:113875114-113875242	NONHSAT073741

Variant related genes	Relation type
IL1RN	TF binding region
IL1RN	CpG island
ENSG00000136689	chromatin interactions

Extended variants
information (count: 90 )
Associated
traits (count: 56 )

Variant overlapped rSNPs/rCNVs (count:90 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4251959	chr2:113874122-113874123	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs143883115	chr2:113874166-113874167	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs4251960	chr2:113874177-113874178	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs115996783	chr2:113874187-113874188	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs185533138	chr2:113874208-113874209	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs532789494	chr2:113874214-113874215	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs371651978	chr2:113874384-113874385	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs552797129	chr2:113874391-113874392	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs36215121	chr2:113874415-113874416	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs190245410	chr2:113874416-113874417	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs550699958	chr2:113874424-113874425	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs571421612	chr2:113874427-113874428	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs568378658	chr2:113874432-113874433	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs183022646	chr2:113874433-113874434	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs375284291	chr2:113874442-113874443	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs569598663	chr2:113874464-113874465	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs4251961	chr2:113874467-113874468	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs187644749	chr2:113874470-113874471	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs572158167	chr2:113874508-113874509	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs4252037	chr2:113874512-113874513	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs45488591	chr2:113874563-113874564	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs45462902	chr2:113874574-113874575	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs4251962	chr2:113874642-113874643	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs45594435	chr2:113874653-113874654	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs184000277	chr2:113874689-113874690	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs368017194	chr2:113874691-113874692	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs528612110	chr2:113874693-113874694	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs4251964	chr2:113874694-113874695	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs532853656	chr2:113874695-113874696	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs140675426	chr2:113874743-113874744	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs189142550	chr2:113874756-113874757	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs375244581	chr2:113874783-113874784	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs4251966	chr2:113874792-113874793	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs77620077	chr2:113874831-113874832	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs74811692	chr2:113874832-113874833	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs568521315	chr2:113874849-113874850	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs114430178	chr2:113874861-113874862	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs55777534	chr2:113874870-113874871	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs569658896	chr2:113874937-113874938	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs534414085	chr2:113874958-113874959	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs4251967	chr2:113874968-113874969	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs36215114	chr2:113874969-113874970	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs115558481	chr2:113874981-113874982	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs373510993	chr2:113875019-113875020	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs534788405	chr2:113875021-113875022	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs554394233	chr2:113875028-113875029	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs574566529	chr2:113875035-113875036	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs183652309	chr2:113875056-113875057	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs11677397	chr2:113875081-113875082	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs369021038	chr2:113875116-113875117	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:56)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Colorectal cancer	16912164	CNVD
Ischaemic stroke	16980335	CNVD
Acute myeloid leukemia	18000384	CNVD
Nephronophthisis	17901113	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Myelofibrosis	22110671	CNVD

Chromatin state (count:102 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:113868600-113875400	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr2:113871400-113874800	Enhancers	NHEK	skin
3	chr2:113871400-113875000	Bivalent Enhancer	HepG2	liver
4	chr2:113871400-113875400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr2:113871600-113874600	Weak transcription	Gastric	stomach
6	chr2:113871600-113875400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr2:113871800-113874600	Enhancers	GM12878-XiMat	blood
8	chr2:113871800-113875400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr2:113872600-113875600	Enhancers	Primary B cells from peripheral blood	blood
10	chr2:113872800-113874800	Enhancers	Primary T helper cells fromperipheralblood	blood
11	chr2:113872800-113875000	Enhancers	Primary T cells from cord blood	blood
12	chr2:113872800-113875000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
13	chr2:113873000-113874400	Enhancers	Esophagus	oesophagus
14	chr2:113873000-113874600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
15	chr2:113873000-113874800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
16	chr2:113873000-113874800	Enhancers	Primary T helper naive cells from peripheral blood	blood
17	chr2:113873000-113874800	Enhancers	Fetal Thymus	thymus
18	chr2:113873000-113875200	Enhancers	Primary T helper cells PMA-I stimulated	--
19	chr2:113873000-113875200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
20	chr2:113873000-113875400	Enhancers	Stomach Mucosa	stomach
21	chr2:113873000-113875600	Enhancers	Primary hematopoietic stem cells	blood
22	chr2:113873000-113875600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
23	chr2:113873200-113874400	Enhancers	Primary T cells fromperipheralblood	blood
24	chr2:113873200-113874600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
25	chr2:113873200-113874600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
26	chr2:113873200-113874800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
27	chr2:113873200-113874800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
28	chr2:113873200-113874800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
29	chr2:113873200-113875400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr2:113873200-113875400	Enhancers	Spleen	Spleen
31	chr2:113873200-113876000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr2:113873400-113874400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
33	chr2:113873400-113874400	Enhancers	Thymus	Thymus
34	chr2:113873400-113874400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
35	chr2:113873400-113874600	Enhancers	Primary T killer memory cells from peripheral blood	blood
36	chr2:113873400-113874800	Enhancers	Primary B cells from cord blood	blood
37	chr2:113873400-113875000	Weak transcription	Lung	lung
38	chr2:113873400-113875600	Enhancers	Duodenum Mucosa	Duodenum
39	chr2:113873600-113874200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
40	chr2:113873600-113874400	Enhancers	Adipose Nuclei	Adipose
41	chr2:113873600-113874400	Enhancers	Sigmoid Colon	Sigmoid Colon
42	chr2:113873600-113875400	Weak transcription	Placenta	Placenta
43	chr2:113873600-113876000	Enhancers	Placenta Amnion	Placenta Amnion
44	chr2:113873600-113876000	Enhancers	Rectal Mucosa Donor 31	rectum
45	chr2:113873800-113874200	Weak transcription	NHDF-Ad	bronchial
46	chr2:113874000-113874200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr2:113874000-113874200	Enhancers	Fetal Muscle Trunk	muscle
48	chr2:113874000-113875600	Enhancers	HMEC	breast
49	chr2:113874200-113874400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr2:113874200-113876000	Enhancers	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links